← Eichor
Study identifier: NCT07145957 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?

Condition: Primary Reverse Total Shoulder Arthroplasty  ·  Sponsor: University of Florida

PhaseN/A
Planned participants64
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersYes

About this study

Difficulty with internal rotation (IR) after reverse shoulder arthroplasty (RSA) is common. Current rehabilitation protocols may not optimize IR. The investigator's objective is to assess the impact of prehabilitation focused on IR strengthening and mobility on RSA outcomes. The investigators will perform a prospective, randomized control trial to achieve the specific aim: assessing range of motion, strength, patient-reported outcomes, and activities of daily living requiring internal rotation between control and prehabilitation cohorts, with the prehabilitation patients receiving 6 weeks of treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Jonathan Wright, MD  ·  (352) 273-7374  ·  wrightjo@ortho.ufl.edu

Aimee Struk, MEd  ·  (352) 273-7419  ·  strukam@ortho.ufl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Florida Department of Orthopaedics and RehabilitationGainesville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07145957